Cancer diagnostics News and Research

RSS

Bioengineers develop continuously tunable method to find and quantify DNA, RNA biomarkers

A Rice University laboratory has developed a continuously tunable method to find and quantify DNA and RNA biomarkers.

20 Oct 2015

New research seeks to improve understanding of how breast cancer starts

Dr Michalak was awarded a highly competitive, four-year career development fellowship from the National Breast Cancer Foundation for her research into breast stem cells. The funding is helping to further her research, which seeks to improve our understanding of how breast cancer starts.

20 Oct 2015

Lightpoint Medical's LightPath Imaging System now CE marked

Lightpoint Medical, an innovative medical device company specializing in imaging technologies, announced today that the LightPath Imaging System is now CE marked, enabling the launch of the device in Europe.

19 Oct 2015

Johns Hopkins members to be honored with American Academy of Nursing's Fellows recognition

Faculty members at the Johns Hopkins School of Nursing will be honored in all three categories of the American Academy of Nursing's Fellows recognition. Sharon Kozachik, PhD, RN, and Jennifer Wenzel, PhD, RN, CCM, will be inducted as Fellows, Laura Gitlin, PhD, will be awarded an Honorary fellowship, and Fannie Gaston-Johansson, PhD, RN, FAAN, will be recognized as a Living Legend—the academy's highest distinction.

16 Oct 2015

EKF’s PointMan™ used in cancer biopsy research

EKF, announces results from a study involving EKF Molecular’s PointMan™ DNA enrichment technology have been published in Clinical Cancer Research.

From EKF Diagnostics 15 Oct 2015

Quest Diagnostics provides Dako’s PD-L1 complementary diagnostic test for non-squamous non-small cell carcinoma

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it now provides clinical laboratory testing using the PD-L1 IHC 28-8 pharmDx immunohistochemistry test, available through Dako, an Agilent Technologies company.

From Quest Diagnostics 13 Oct 2015

Ambry Genetics presents groundbreaking TP53 gene data at ASHG; TP53 linked to breast cancer

Ambry Genetics (Ambry), a leader in clinical genetic diagnostics and genetics software solutions, has announced new data affirming the effectiveness of multi-gene panel testing (MGPT) in identifying TP53 gene mutations in people who might otherwise not have been tested. The findings, presented as a poster at the American Society of Human Genetics (ASHG) 2015 Annual Meeting in Baltimore, includes data collected from more than 25,000 individuals having TP53 testing, of which 187 were positive. The tested cohort is the largest to date from a single testing laboratory.

9 Oct 2015

Jumping genes: a marker for early cancer diagnosis? An interview with Dr Kazazian

In the genome of every human being, there are about 80-100 active LINE-1s that are capable of mobilizing by a copy and paste mechanism to a new location in the genome.

6 Oct 2015

Oxford Gene Technology launches Cytocell FISH probe for bladder cancer

Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius® P16/3c/7c/17c Probe Kit, a cost-effective, ready-to-use fluorescence in situ hybridisation (FISH) probe kit for non-invasive detection of bladder cancer — for sale in Europe.

From Oxford Gene Technology 6 Oct 2015

New smartphone-based device can reliably perform molecular diagnoses at low cost

NIBIB-funded researchers at the Massachusetts General Hospital have developed a smartphone-based device that can reliably carry out molecular diagnoses in under an hour for approximately two dollars per patient. The device could enable point-of-care cancer diagnostics in low- to middle-income or remote areas, which often have high rates of mortality from cancer due to missed opportunities for treatment.

6 Oct 2015

UT Southwestern announces launch of new health initiative

UT Southwestern Medical Center today announced the launch of "Call Out Cancer," a new health initiative designed to promote awareness, early detection, and prevention of all types of cancer.

6 Oct 2015

Testosterone therapy not associated with increased risk of aggressive prostate cancer: Study

A new population-based study from The University of Texas Medical Branch at Galveston showed for the first time that exposure to testosterone therapy over a five-year period was not associated with an increased risk of aggressive prostate cancer. Further, risk of high-grade prostate cancer did not increase according to the total number of testosterone injections.

5 Oct 2015

Scientists make progress toward finding new ways to 'smell' signs of cancer

Scientists have been exploring new ways to "smell" signs of cancer by analyzing what's in patients' breath. In ACS' journal Nano Letters, one team now reports new progress toward this goal. The researchers have developed a small array of flexible sensors, which accurately detect compounds in breath samples that are specific to ovarian cancer.

1 Oct 2015

Primary care doctors ill-prepared to cope with rising demand for cancer care in high-income countries

Leading primary care professionals and cancer experts will warn at the Royal College of General Practitioners annual congress in Glasgow, UK that primary care doctors will not be able to cope with the rising demand for cancer care in high-income countries – predicted to double within the next 15 years.

1 Oct 2015

LDCT lung cancer screening does not lead to unnecessary treatment

Lung cancer screening programs that utilize standardized reporting and include cardiothoracic surgeons as part of a multidisciplinary team can successfully be adopted into clinical practice without an increase in surgical intervention for non-cancerous disease, according to an article in the October 2015 issue of The Annals of Thoracic Surgery.

1 Oct 2015

Cornell University, MSKCC jointly open new $10 million Center of Cancer Nanotechnology Excellence

Cornell University, in partnership with Memorial Sloan Kettering Cancer Center, is opening a new $10 million Center of Cancer Nanotechnology Excellence that brings together scientists, engineers, biologists and physicians to develop and translate new cancer care applications based on nanotechnology.

30 Sep 2015

Cancer treatment does not affect pregnancy outcome, shows new study

Women who are pregnant when diagnosed with cancer can start treatment for their disease immediately and do not need to terminate their pregnancy due to worries over the effects of therapy on the development of their child.

29 Sep 2015

Study may lead to new insights on use of aspirin in GI cancer

Aspirin improves survival in patients with tumours situated throughout the gastrointestinal (GI) tract, results from a large study in The Netherlands show. This is the first time that survival data from patients with tumours in different GI locations have been analysed at the same time; previously, only one type of cancer, usually colorectal, was studied.

28 Sep 2015

Portuguese researchers find significant differences between smokers and non-smokers who develop NSCLC

Tobacco smoke is known to be the main risk factor for non-small cell lung cancer (NSCLC), although non-smokers can get it too. The incidence among non-smokers is increasing in many countries. Now a group of Portuguese researchers has found significant differences in clinical particularities and survival between smokers and non-smokers who develop NSCLC.

28 Sep 2015

Pediatric cancer diagnosis can take a significant toll on financial well-being of families

Almost one-third of families whose children were being treated for cancer faced food, housing or energy insecurity and one-quarter lost more than 40 percent of household income, according to a new study from Dana-Farber/Boston Children's Cancer and Blood Disorders Center.

26 Sep 2015

Cancer diagnostics News and Research

Bioengineers develop continuously tunable method to find and quantify DNA, RNA biomarkers

New research seeks to improve understanding of how breast cancer starts

Lightpoint Medical's LightPath Imaging System now CE marked

Johns Hopkins members to be honored with American Academy of Nursing's Fellows recognition

EKF’s PointMan™ used in cancer biopsy research

Quest Diagnostics provides Dako’s PD-L1 complementary diagnostic test for non-squamous non-small cell carcinoma

Ambry Genetics presents groundbreaking TP53 gene data at ASHG; TP53 linked to breast cancer

Jumping genes: a marker for early cancer diagnosis? An interview with Dr Kazazian

Oxford Gene Technology launches Cytocell FISH probe for bladder cancer

New smartphone-based device can reliably perform molecular diagnoses at low cost

UT Southwestern announces launch of new health initiative

Testosterone therapy not associated with increased risk of aggressive prostate cancer: Study

Scientists make progress toward finding new ways to 'smell' signs of cancer

Primary care doctors ill-prepared to cope with rising demand for cancer care in high-income countries

LDCT lung cancer screening does not lead to unnecessary treatment

Cornell University, MSKCC jointly open new $10 million Center of Cancer Nanotechnology Excellence

Cancer treatment does not affect pregnancy outcome, shows new study

Study may lead to new insights on use of aspirin in GI cancer

Portuguese researchers find significant differences between smokers and non-smokers who develop NSCLC

Pediatric cancer diagnosis can take a significant toll on financial well-being of families

Cancer Research - Second Edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News